Mackenzie Financial’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $70.6M | Buy |
333,295
+206,785
| +163% | +$40.6M | 0.07% | 214 |
|
|
2026
Q1 | $24.8M | Buy |
126,510
+21,664
| +21% | +$4.21M | 0.03% | 372 |
|
|
2025
Q4 | $18.4M | Sell |
104,846
-52,509
| -33% | -$9.56M | 0.02% | 394 |
|
|
2025
Q3 | $30M | Buy |
157,355
+888
| +0.6% | +$158K | 0.04% | 327 |
|
|
2025
Q2 | $28.1M | Buy |
156,467
+143,935
| +1,149% | +$25M | 0.04% | 310 |
|
|
2025
Q1 | $2.12M | Buy |
12,532
+1,530
| +14% | +$251K | ﹤0.01% | 770 |
|
|
2024
Q4 | $1.66M | Buy |
11,002
+1,518
| +16% | +$236K | ﹤0.01% | 824 |
|
|
2024
Q3 | $1.47M | Sell |
9,484
-661
| -7% | -$98.7K | ﹤0.01% | 789 |
|
|
2024
Q2 | $1.39M | Sell |
10,145
-8,826
| -47% | -$1.21M | ﹤0.01% | 795 |
|
|
2024
Q1 | $2.53M | Buy |
18,971
+840
| +5% | +$109K | ﹤0.01% | 694 |
|
|
2023
Q4 | $2.5M | Sell |
18,131
-17,962
| -50% | -$2.36M | ﹤0.01% | 687 |
|
|
2023
Q3 | $4.37M | Buy |
36,093
+19,142
| +113% | +$2.55M | 0.01% | 568 |
|
|
2023
Q2 | $2.36M | Sell |
16,951
-4,066
| -19% | -$561K | ﹤0.01% | 688 |
|
|
2023
Q1 | $2.97M | Sell |
21,017
-2,227
| -10% | -$319K | ﹤0.01% | 656 |
|
|
2022
Q4 | $3.64M | Sell |
23,244
-29,055
| -56% | -$4.18M | 0.01% | 570 |
|
|
2022
Q3 | $6.42M | Sell |
52,299
-6,766
| -11% | -$891K | 0.01% | 480 |
|
|
2022
Q2 | $7.85M | Buy |
59,065
+21,079
| +55% | +$2.87M | 0.01% | 469 |
|
|
2022
Q1 | $5.2M | Sell |
37,986
-25,568
| -40% | -$3.56M | 0.01% | 571 |
|
|
2021
Q4 | $11M | Buy |
63,554
+423
| +0.7% | +$64.4K | 0.01% | 461 |
|
|
2021
Q3 | $9.17M | Buy |
63,131
+23,050
| +58% | +$3.37M | 0.01% | 473 |
|
|
2021
Q2 | $5.29M | Sell |
40,081
-19,651
| -33% | -$2.57M | 0.01% | 549 |
|
|
2021
Q1 | $7.67M | Buy |
59,732
+40,652
| +213% | +$5.01M | 0.01% | 463 |
|
|
2020
Q4 | $2.27M | Sell |
19,080
-4,970
| -21% | -$606K | ﹤0.01% | 581 |
|
|
2020
Q3 | $2.75M | Buy |
24,050
+9,716
| +68% | +$1.15M | 0.01% | 496 |
|
|
2020
Q2 | $1.63M | Buy |
14,334
+10,632
| +287% | +$1.13M | ﹤0.01% | 596 |
|
|
2020
Q1 | $297K | Buy |
3,702
+391
| +12% | +$40.5K | ﹤0.01% | 909 |
|
|
2019
Q4 | $354K | Buy |
3,311
+1,341
| +68% | +$140K | ﹤0.01% | 927 |
|
|
2019
Q3 | $211K | Sell |
1,970
-11
| -0.6% | -$1.13K | ﹤0.01% | 949 |
|
|
2019
Q2 | $202K | Sell |
1,981
-353
| -15% | -$33.9K | ﹤0.01% | 1036 |
|
|
2019
Q1 | $210K | Sell |
2,334
-52,594
| -96% | -$4.56M | ﹤0.01% | 1165 |
|
|
2018
Q4 | $4.57M | Sell |
54,928
-18,873
| -26% | -$1.77M | 0.01% | 513 |
|
|
2018
Q3 | $7.96M | Buy |
73,801
+6,144
| +9% | +$674K | 0.02% | 385 |
|
|
2018
Q2 | $7.44M | Sell |
67,657
-106,115
| -61% | -$11.1M | 0.02% | 372 |
|
|
2018
Q1 | $17.4M | Sell |
173,772
-84,233
| -33% | -$8.63M | 0.04% | 252 |
|
|
2017
Q4 | $25.4M | Buy |
258,005
+62,505
| +32% | +$5.93M | 0.06% | 235 |
|
|
2017
Q3 | $18.3M | Buy |
195,500
+40,164
| +26% | +$4.26M | 0.1% | 191 |
|
|
2017
Q2 | $17.3M | Sell |
155,336
-49,238
| -24% | -$5.21M | 0.1% | 192 |
|
|
2017
Q1 | $20.1M | Buy |
204,574
+94,011
| +85% | +$8.96M | 0.12% | 183 |
|
|
2016
Q4 | $10.2M | Sell |
110,563
-46,690
| -30% | -$4.02M | 0.06% | 230 |
|
|
2016
Q3 | $13.3M | Sell |
157,253
-2,699
| -2% | -$227K | 0.08% | 192 |
|
|
2016
Q2 | $13M | Sell |
159,952
-1,318
| -0.8% | -$100K | 0.07% | 224 |
|
|
2016
Q1 | $11.5M | Buy |
161,270
+12,013
| +8% | +$806K | 0.1% | 191 |
|
|
2015
Q4 | $10.6M | Buy |
149,257
+137,240
| +1,142% | +$9.23M | 0.07% | 238 |
|
|
2015
Q3 | $739K | Buy |
12,017
+1,571
| +15% | +$110K | ﹤0.01% | 594 |
|
|
2015
Q2 | $758K | Buy |
10,446
+954
| +10% | +$70.4K | ﹤0.01% | 610 |
|
|
2015
Q1 | $729K | Buy |
9,492
+306
| +3% | +$21.9K | ﹤0.01% | 599 |
|
|
2014
Q4 | $616K | Buy |
9,186
+580
| +7% | +$36.6K | ﹤0.01% | 609 |
|
|
2014
Q3 | $522K | Sell |
8,606
-836
| -9% | -$51.5K | ﹤0.01% | 615 |
|
|
2014
Q2 | $554K | Buy |
9,442
+3,846
| +69% | +$225K | ﹤0.01% | 579 |
|
|
2014
Q1 | $324K | Buy |
+5,596
| New | +$300K | ﹤0.01% | 614 |
|
Other funds holding DGX
EIG
Mackenzie Financial's DGX Position: Q2 2026 in Review
Mackenzie Financial increased its Quest Diagnostics (DGX) stake by 163% in Q2 2026, buying an estimated $40.6M and bringing the position to 333,295 shares worth $70.6M. The position accounts for 0.07% of the portfolio, ranked #214.
Mackenzie Financial first reported a position in DGX in Q1 2014 and has held it in 50 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Mackenzie Financial held 333,295 shares of Quest Diagnostics worth $70.6M as of Q2 2026.
- Mackenzie Financial bought 206,785 Quest Diagnostics shares in Q2 2026, an estimated $40.6M.
- Quest Diagnostics made up 0.07% of Mackenzie Financial's portfolio in Q2 2026, its #214 holding.
- Mackenzie Financial first reported a position in Quest Diagnostics in Q1 2014 and has held it in 50 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.